Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More

Amid the bombast of Tuesday’s presidential debate, viewers caught some discussion about the response to the coronavirus pandemic and efforts to develop a COVID-19 vaccine. In the crosstalk, the president made an unsupported claim that we are weeks away from having vaccines.

It’s true that some pharmaceutical companies are already manufacturing their COVID-19 vaccine candidates for broader use. This production ensures that vaccine product is ready for distribution upon receiving a regulatory decision. But companies undertake this “at-risk” manufacturing because they don’t yet know how well their vaccines will work or if they’ll be approved. The industry is pushing back, even... Read more »


UNDERWRITERS AND PARTNERS

          

          

            
Author: Frank Vinluan

Source : https://xconomy.com/national/2020/10/02/bio-roundup-mesos-miss-pfizers-cancer-bet-vaccine-promise-more/


Date : 2020-10-02T14:19:59.000Z

Post a Comment

Previous Post Next Post